Cathelicidins: A Novel Therapy for the Treatment of Intestinal Fibrosis?
Main Authors: | Stefania Vetrano, PhD, Marco Genua, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Cellular and Molecular Gastroenterology and Hepatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352345X14000113 |
Similar Items
-
TRPing Up Fibrosis: A Novel Role for TRPA1 in Intestinal Myofibroblasts
by: Simon Andrew Hirota, PhD
Published: (2018-01-01) -
Cathelicidin preserves intestinal barrier function in polymicrobial sepsis
by: Jeffery Ho, et al.
Published: (2020-02-01) -
Cystic Fibrosis and Genotype-Dependent Therapy: Is There a Need for a Sex-Specific Therapy?
by: Neil A. Bradbury PhD
Published: (2020-07-01) -
Antifibrogenic Effects of the Antimicrobial Peptide Cathelicidin in Murine Colitis-Associated FibrosisSummary
by: Jun Hwan Yoo, et al.
Published: (2015-01-01) -
Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report
by: Toshihisa Kimura MD, PhD, et al.
Published: (2020-11-01)